The Yorkshire Post reads "Keyhole surgery on wing ready for take-off", a detailed article written by Ros Snowdon, the City Editor of the paper including quotes from an interview with CEO Graham Bowland.

Surgical Innovations Group Plc logo Surgical Innovations Group Plc (LON: SUN)'s stock had its �buy� rating reiterated by investment analysts at Panmure Gordon in a note issued to investors on Wednesday, Analyst Ratings Network reports.

Surgical Innovations Group Plc logo Surgical Innovations Group Plc (LON: SUN)'s stock had its �buy� rating reaffirmed by research analysts at Panmure Gordon in a report released on Wednesday, Analyst Ratings Network.

"Cancer patients, in general, benefit from diagnosis of their condition at the earliest possible stage, which may lead to earlier treatments and, potentially, more favorable outcomes," said Bryan Hanson, Group President, Surgical Solutions, Covidien ...

After setting up its Innovation Center in Shanghai, the first outside the US and Europe, last October the company acquired China Kanghui Holdings and formed a strategic alliance with China-based LifeTech Scientific Corporation (both in Oct 2012).

OF YEAR AGO ESTIMATE EST EPS 08 May AMC Q1 2013 AcelRx Pharmaceuticals, Inc. -0.27 8 -0.36 08 May AMC Q1 2013 ADA ES INC -0.20 3 -0.14 08 May AMC Q1 2013 American Financial Group 0.83 6 0.86 08 May AMC Q1 2013 Ashford Hospitality .... PLC -0.39 10 -0 ...

Speaker: Rear Adm. Scott F. Giberson, U.S. assistant surgeon general, Director Commissioned Corps Personnel and Readiness, and Professional Officer, Pharmacy.

YORK, 13th May 2013 - Tissue Regenix Group plc ("Tissue Regenix" or "the Group"), the regenerative medical devices company which uses animal or human tissue to replace damaged or worn out parts of the human body, today announces its unaudited ...

Commenting on the launch, Amitabh Chaudhry, MD & CEO, HDFC Life said, �Customer centric product innovation has been our prime focus at HDFC Life.

Allergan, Inc. is a multi-specialty health care company focused on developing and commercializing innovative pharmaceuticals, biologics and medical devices.